DE69729201D1 - Sulfonfluoride zur behandlung von der alzheimerischen krankheit - Google Patents
Sulfonfluoride zur behandlung von der alzheimerischen krankheitInfo
- Publication number
- DE69729201D1 DE69729201D1 DE69729201T DE69729201T DE69729201D1 DE 69729201 D1 DE69729201 D1 DE 69729201D1 DE 69729201 T DE69729201 T DE 69729201T DE 69729201 T DE69729201 T DE 69729201T DE 69729201 D1 DE69729201 D1 DE 69729201D1
- Authority
- DE
- Germany
- Prior art keywords
- fluoride
- disease
- individual
- treating
- alzheimerischen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08705858 US5798392C1 (en) | 1996-08-28 | 1996-08-28 | Sulfonyl fluorides for the treatment of alzheimer's disease |
PCT/US1997/015024 WO1998008497A1 (en) | 1996-08-28 | 1997-08-26 | Sulfonyl fluorides for the treatment of alzheimer's disease |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69729201D1 true DE69729201D1 (de) | 2004-06-24 |
DE69729201T2 DE69729201T2 (de) | 2005-04-21 |
Family
ID=24835244
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69729201T Expired - Lifetime DE69729201T2 (de) | 1996-08-28 | 1997-08-26 | Sulfonfluoride zur behandlung von der alzheimerischen krankheit |
Country Status (8)
Country | Link |
---|---|
US (1) | US5798392C1 (de) |
EP (1) | EP0921790B1 (de) |
JP (1) | JP2000517317A (de) |
AT (1) | ATE267010T1 (de) |
AU (1) | AU731755B2 (de) |
CA (1) | CA2264582C (de) |
DE (1) | DE69729201T2 (de) |
WO (1) | WO1998008497A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030045005A1 (en) * | 2000-10-17 | 2003-03-06 | Michael Seul | Light-controlled electrokinetic assembly of particles near surfaces |
AU2002243920A1 (en) * | 2001-02-08 | 2002-08-19 | Nps Pharmaceuticals, Inc. | Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same |
US8618167B2 (en) * | 2001-11-06 | 2013-12-31 | Board Of Regents, The University Of Texas System | Methods of attenuating cognitive deficits with sulfonyl fluorides |
US20100256243A1 (en) | 2009-04-03 | 2010-10-07 | Federica Pericle | Dosing Regimen for the Treatment of Alzheimer's Disease With Sulfonyl Fluorides |
US8846061B1 (en) | 2011-03-08 | 2014-09-30 | Mark S. Bezzek | Multivitamin-mineral regimens for longevity and wellness |
US8349376B1 (en) * | 2011-03-08 | 2013-01-08 | Bezzek Mark S | Anti-dementia regimen |
EP3628315A1 (de) | 2018-09-28 | 2020-04-01 | Université de Caen Normandie | Kombination aus acetylcholinesterase-inhibitor und 5-ht4-rezeptoragonist als neuroprotektives mittel zur behandlung von neurodegenerativen krankheiten |
-
1996
- 1996-08-28 US US08705858 patent/US5798392C1/en not_active Expired - Lifetime
-
1997
- 1997-08-26 EP EP97938628A patent/EP0921790B1/de not_active Expired - Lifetime
- 1997-08-26 AU AU40915/97A patent/AU731755B2/en not_active Ceased
- 1997-08-26 DE DE69729201T patent/DE69729201T2/de not_active Expired - Lifetime
- 1997-08-26 WO PCT/US1997/015024 patent/WO1998008497A1/en active IP Right Grant
- 1997-08-26 JP JP10511856A patent/JP2000517317A/ja active Pending
- 1997-08-26 AT AT97938628T patent/ATE267010T1/de not_active IP Right Cessation
- 1997-08-26 CA CA002264582A patent/CA2264582C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE267010T1 (de) | 2004-06-15 |
DE69729201T2 (de) | 2005-04-21 |
AU4091597A (en) | 1998-03-19 |
EP0921790B1 (de) | 2004-05-19 |
EP0921790A1 (de) | 1999-06-16 |
CA2264582C (en) | 2009-01-06 |
WO1998008497A1 (en) | 1998-03-05 |
US5798392A (en) | 1998-08-25 |
CA2264582A1 (en) | 1998-03-05 |
AU731755B2 (en) | 2001-04-05 |
EP0921790A4 (de) | 2000-11-02 |
JP2000517317A (ja) | 2000-12-26 |
US5798392C1 (en) | 2002-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68919358T2 (de) | Zusammensetzung zur behandlung der schizophrenie. | |
ATE241365T1 (de) | Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen | |
RU94027680A (ru) | Паращитовидный гормон и ралоксифон для увеличения массы кости, фармацевтический состав и способ увеличения костной массы | |
ATE140388T1 (de) | Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen | |
ATE113846T1 (de) | Therapeutische zusammensetzungen für die behandlung von myocard-infarkten. | |
ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
KR950031060A (ko) | 골다공증 치료용 약제학적 조성물 | |
DE69424777T2 (de) | 3,4-diarylchromane zur behandlung von dermatitis | |
HUP9900511A2 (hu) | Legalább egy béta-adrenergiás agonista alkalmazása P anyag antagonistaként és kozmetikai kezelési eljárás | |
DE69625682T2 (de) | Verfahren zur behandlung von entzündungen und zusammensetzungen dafür | |
DE69729201D1 (de) | Sulfonfluoride zur behandlung von der alzheimerischen krankheit | |
ATE225177T1 (de) | Verwendung von (+)mefloquine zur behandlung von malaria | |
EA200000242A1 (ru) | Применение фанхинона для лечения болезни альцгеймера | |
DE59902666D1 (de) | Edelfosin zur behandlung von hirntumoren | |
BR9508021A (pt) | Composição farmacêutica para o tratamento de distúrbios esquizofrênicos, uso de um agente imunossupressor, e, processo de tratamento de um paciente esquizofrênico | |
EA200401295A1 (ru) | Статиновая терапия для усиления поддержания когнитивной функции | |
DE69739482D1 (de) | Therapeutische formulierungen, die schlangen- und/oder insektengift enthalten, zur prophylaxe und therapie von neoplasmen | |
ATE293994T1 (de) | Multivalente rekombinante antikörper zur behandlung von hrv infektionen | |
ATE147978T1 (de) | Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit | |
DE69800906T2 (de) | Verwendung von Olanzapine zur Herstellung eines Arzneimittels zur Behandlung der zerebralen fokalen Ischämie | |
ATE350026T1 (de) | Erhaltung von körpereigenen proteinen | |
MY110416A (en) | Composition for the treatment of schizophrenia. | |
UA9522A (uk) | Спосіб лікування аутоімунного тиреоідиту |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |